Page 95 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

Table 7. Eligibility criteria for enrollment in protocols with palliative intent in chronological order of starting enrollment year

Center, Country Term used Age (yr) PSA Gleason # biopsy Imaging Stage Behavioral indication
[Pubmed ID] (ng/mL) score cores /% (other than patients’
Enrollment years cores choice or preference)
Howard University EM /WW – – – – – Stage A and B –
College of
Medicine, US 138
[1600492]

1967-1989
Orebro Medical Deferred Any (all patients >75 – – – – T0-T2 –
Center, Sweden 139 treatment were not given any
[7933233] initial treatment from
1978-79)
1977-1984
Northern WW – – – – Normal 71% T1-2 and –
Stockholm region, bone scan 29% with T3
Sweden 140
[17467883]

1978-1982
Freeman Hospital, Deferred – – – – – – Patients without
UK 141 treatment symptoms after initial
[3191340] outflow tract surgery or
biopsy
1978-1985
Western General Deferred – – – – – incidental –
Hospital, UK 142 treatment (T0/stage A) or
[8343901] localized *T1/stage
B1/B2)
1978-1990

50